The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 21, 2025

Filed:

Mar. 09, 2023
Applicant:

Massachusetts Mutual Life Insurance Company, Springfield, MA (US);

Inventors:

Marc Maier, Springfield, MA (US);

Shanshan Li, Springfield, MA (US);

Hayley Carlotto, Springfield, MA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G16H 10/60 (2018.01); G06N 20/00 (2019.01); G16H 10/20 (2018.01); G16H 20/10 (2018.01); G16H 50/70 (2018.01);
U.S. Cl.
CPC ...
G16H 10/60 (2018.01); G06N 20/00 (2019.01); G16H 10/20 (2018.01); G16H 20/10 (2018.01); G16H 50/70 (2018.01);
Abstract

A suite of fluidless predictive machine learning models includes a fluidless mortality module, smoking propensity model, and prescription fills model. The fluidless machine learning models are trained against a corpus of historical underwriting applications of a sponsoring enterprise, including clinical data of historical applicants. A data appended procedure supplements historical applications data with public records and credit risks. Various features of this data are engineered for improved predictive characteristics. Fluidless models are trained by application of a random forest ensemble including survival, regression and classification models. The trained models produce high-resolution, individual mortality scores. A fluidless underwriting protocol runs these predictive models to assess mortality risk and other risk attributes of a fluidless application that excludes clinical data to determine whether to present an accelerated underwriting offer. If any of the fluidless predictive models determines a high risk target, the applicant is required to submit clinical data.


Find Patent Forward Citations

Loading…